DnB Asset Management’s Coherus Oncology, Inc. Common Stock CHRS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q4 | – | Sell |
-18,290
| Closed | -$294K | – | 670 |
|
|
2021
Q3 | $294K | Sell |
18,290
-4,363
| -19% | -$70.1K | ﹤0.01% | 633 |
|
|
2021
Q2 | $313K | Buy |
22,653
+2,368
| +12% | +$32.7K | ﹤0.01% | 622 |
|
|
2021
Q1 | $296K | Sell |
20,285
-742
| -4% | -$10.8K | ﹤0.01% | 629 |
|
|
2020
Q4 | $365K | Buy |
21,027
+1,584
| +8% | +$27.5K | ﹤0.01% | 612 |
|
|
2020
Q3 | $357K | Buy |
19,443
+1,626
| +9% | +$29.8K | ﹤0.01% | 598 |
|
|
2020
Q2 | $318K | Buy |
+17,817
| New | +$318K | ﹤0.01% | 591 |
|